Aspirin, NSAIDs, and COX-2 inhibitors in cardiovascular disease: Possible interactions and implications for treatment of rheumatoid arthritis
Authors:
- Tobias KurthTKTobias Kurth
- Charles H. HennekensCHCharles H. Hennekens
- Julie E. BuringJBJulie E. Buring
- J. Michael GazianoJGJ. Michael Gaziano
- 1 September 2004
- journal article
- research article
- Published by Springer Nature in Current Rheumatology Reports
- Vol. 6 (5) , 351-356
Abstract
Aspirin, nonsteroidal antiinflammatory drugs (NSAIDs), and cyclooxygenase-2 (COX-2) inhibitors are widely used in patients with rheumatoid arthritis. Aspirin has the largest and most persuasive body of randomized trial evidence to support its use in secondary prevention for cardiovascular disease (CVD) and primary prevention for myocardial infarction. There is, however, a possible deleterious interaction between aspirin and NSAIDs on CVD that requires further research. Aspirin, NSAIDs, and to a lesser extent COX-2 inhibitors are associated with increased gastrointestinal side effects and bleeding, alone and in combination. The more widespread and appropriate use of aspirin in patients with rheumatoid arthritis will avoid many premature deaths in secondary prevention for CVD and first myocardial infarctions in primary prevention.Keywords
This publication has 49 references indexed in Scilit:
- Nonsteroidal Antiinflammatory Drugs and the Risk of Myocardial Infarction in the General PopulationCirculation, 2004
- The role of aspirin in cardiovascular diseases – forgotten benefits?Expert Opinion on Pharmacotherapy, 2004
- Giving aspirin and ibuprofen after myocardial infarctionBMJ, 2003
- Differential Effects of Selective Cyclooxygenase-2 Inhibitors on Endothelial Function in Salt-Induced HypertensionCirculation, 2003
- Cardiovascular Morbidity and Mortality in Women Diagnosed With Rheumatoid ArthritisCirculation, 2003
- Celecoxib Does Not Affect the Antiplatelet Activity of Aspirin in Healthy VolunteersThe Journal of Clinical Pharmacology, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- Effects of Nonsteroidal Antiinflammatory Drugs on Platelet Function and Systemic HemostasisThe Journal of Clinical Pharmacology, 1995
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989